{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:33:25Z","timestamp":1775183605217,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: Invasive pulmonary aspergillosis (IA) is a common infectious disease in patients with hematological diseases. The prevention, early detection, and establishment of treatment strategies for IA are important. The serum galactomannan antigen (GM) mycological test for IA diagnosis, included in the mycology criteria of the European Organization for Research and Treatment of Cancer-Invasive Fungal Infections Cooperative Group\/National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC\/MSG), is widely used because of its high sensitivity and specificity. However, false-positive results are a concern. Methods: We retrospectively analyzed all GM tests performed at our department in the clinical practice setting between April 2003 and January 2012. Results: Of the 330 cases and 2155 samples analyzed, 540 (25%) were positive (\u22650.5). Among the underlying diseases, positivity rates were the highest for multiple myeloma (MM), with 61.3%. By type, positivity rates for IgG, IgA, Bence-Jones protein, and IgD were 71.7%, 33.3%, 57.1%, and 34.6%, respectively. Seventeen out of eighteen cases that were GM-positive at MM diagnosis were false positives, according to the 2008 EORTC\/MSG criteria. The IgG and GM values were not directly correlated. Of the seventeen false-positive cases identified, two developed IA during anti-myeloma treatments, and GM values did not become negative during the treatment in most cases. Conclusions: Although subclinical IA may be included in a higher GM index, the results may be prone to false positives; particularly in IgG-type MM, the results should thus be interpreted cautiously.<\/jats:p>","DOI":"10.3390\/diseases13040118","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T20:05:56Z","timestamp":1744920356000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["False-Positive Galactomannan Test Results in Multiple Myeloma"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5465-2758","authenticated-orcid":false,"given":"Shingen","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusaku","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Sumitani","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Oura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Sogabe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-7471","authenticated-orcid":false,"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Miki","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima 7708503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0609.2004.00273.x","article-title":"Invasive fungal infections in autologous stem cell transplant recipients: A nation-wide study of 1188 transplanted patients","volume":"73","author":"Jantunen","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/myc.13344","article-title":"Invasive Pulmonary Aspergillosis in Multiple Myeloma patients: A sizeable diagnosis in the era of novel anti-myeloma therapies","volume":"64","author":"Fuchs","year":"2021","journal-title":"Mycoses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2019003","DOI":"10.4084\/mjhid.2019.003","article-title":"International Multicenter Experience in the Treatment Outcome of Invasive Aspergillosis in Immunocompromised Cancer Patients","volume":"11","author":"Hachem","year":"2019","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/jac\/dks111","article-title":"Piperacillin\/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay","volume":"67","author":"Mikulska","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mmcr.2013.11.004","article-title":"Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing","volume":"3","author":"Ng","year":"2014","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1555.e9","DOI":"10.1016\/j.cmi.2020.02.002","article-title":"False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration","volume":"26","author":"Liu","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hung, Y.H., Lai, H.H., Lin, H.C., Sun, K.S., and Chen, C.Y. (2021). Investigating Factors of False-Positive Results of Aspergillus Galactomannan Assay: A Case-Control Study in Intensive Care Units. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.747280"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ajh.21697","article-title":"High incidence of false-positive Aspergillus galactomannan test in multiple myeloma","volume":"85","author":"Mori","year":"2010","journal-title":"Am. J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jinf.2015.10.014","article-title":"Multiple myeloma as a major cause of false-positive galactomannan tests in adult patients with cancer","volume":"72","author":"Ko","year":"2016","journal-title":"J. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/myc.12951","article-title":"Higher frequency of false-positive serum galactomannan tests among older subjects and the association with elevated serum immunoglobulin G levels","volume":"62","author":"Abe","year":"2019","journal-title":"Mycoses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1128\/iai.60.6.2237-2245.1992","article-title":"Rat monoclonal antibodies against Aspergillus galactomannan","volume":"60","author":"Stynen","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_16","first-page":"Cd007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/382224","article-title":"False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam","volume":"38","author":"Viscoli","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1128\/JCM.42.11.5362-5363.2004","article-title":"False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment","volume":"42","author":"Mattei","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/CVI.00479-06","article-title":"Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay","volume":"14","author":"Wheat","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/mmy\/myaa084","article-title":"False-positive galactomannan antigen testing in pulmonary nocardiosis","volume":"59","author":"Haran","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.43.6.2929-2931.2005","article-title":"Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan","volume":"43","author":"Dalle","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/427070","article-title":"False-positive results of Aspergillus enzyme-linked immunosorbent assays for a patient with gastrointestinal graft-versus-host disease taking a nutrient containing soybean protein","volume":"40","author":"Murashige","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1111\/j.1439-0507.2011.02022.x","article-title":"Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases","volume":"54","author":"Girmenia","year":"2011","journal-title":"Mycoses"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1532-5415.2009.02238.x","article-title":"High incidence of false-positive Aspergillus galactomannan test results in patients with aspiration pneumonia","volume":"57","author":"Tomita","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood.V97.6.1604","article-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation","volume":"97","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/514349","article-title":"Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay","volume":"44","author":"Maertens","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/08820138209094130","article-title":"Binding of human IgA myeloma proteins to protein A. Evidence for different binding mechanisms","volume":"11","author":"Biewenga","year":"1982","journal-title":"Immunol. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19740","DOI":"10.1016\/S0021-9258(19)47174-3","article-title":"Protein L: An immunoglobulin light chain-binding bacterial protein. Characterization of binding and physicochemical properties","volume":"264","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/306387a0","article-title":"Immunoglobulin heavy chain binding protein","volume":"306","author":"Haas","year":"1983","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/cncr.22863","article-title":"Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: A study of 56 patients with hematologic cancer","volume":"110","author":"Woods","year":"2007","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cir441","article-title":"Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: Proposal for a new definition","volume":"53","author":"Nucci","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","first-page":"Cd009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0300060518811472","article-title":"Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment","volume":"47","author":"Wang","year":"2019","journal-title":"J. Int. Med. Res."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/4\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:16:48Z","timestamp":1760030208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/4\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["diseases13040118"],"URL":"https:\/\/doi.org\/10.3390\/diseases13040118","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}